The grant awarded for Chadli’s research focuses on a specific protein, UNC45A, that can be used as a promising novel immunotherapeutic target in treating triple-negative breast cancer (TNBC).
"The work our scientists do in their labs relies on the passion, determination and generosity of each team and individual who took part in PaceDay Weekend 2022,” said Jorge C. Cortes, MD, director of the Georgia Cancer Center.